Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
World Journal of Urology
Erschienen in: World Journal of Urology 9/2017

03.02.2017 | Topic Paper

Antibiotic use and the prevention and management of infectious complications in stone disease

verfasst von: Daniel A. Wollin, Adrian D. Joyce, Mantu Gupta, Michael Y. C. Wong, Pilar Laguna, Stavros Gravas, Jorge Gutierrez, Luigi Cormio, Kunjie Wang, Glenn M. Preminger

Erschienen in: World Journal of Urology | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

The importance of assessing perioperative urine/stone cultures and providing appropriate antibiotic prophylaxis prior to shock wave lithotripsy (SWL) or endoscopic intervention cannot be minimized. Urinary tract infection (UTI) is the most common complication relating to stone intervention. Adequate assessment of culture data and adherence to appropriate guidelines may prevent the development of UTI and the potential for post-intervention urosepsis. This review outlines the current evidence for prophylaxis in the prevention of UTI and urosepsis, as well as the interpretation of stone culture data to provide an evidence-based approach for the judicious use of antibiotics in urologic stone practice.
Literatur
1.
Marien T, Mass AY, Shah O (2015) Antimicrobial resistance patterns in cases of obstructive pyelonephritis secondary to stones. Urology 85(1):64–68CrossRefPubMed
2.
Assimos D, Krambeck A, Miller NL, Monga M, Murad MH, Nelson CP et al (2016) Surgical management of stones: American Urological Association/Endourological Society Guideline, part I. J Urol 196(4):1153–1160CrossRefPubMed
3.
Farrell DJ, Morrissey I, De Rubeis D, Robbins M, Felmingham D (2003) A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect 46(2):94–100CrossRefPubMed
4.
Gutierrez J NO, Avila P (2012) Preoperative antibiotics and prevention of sepsis in genitourinary surgery. 3rd edn. Smith AD (ed) Wiley, Chichester
5.
Bootsma AM, Laguna Pes MP, Geerlings SE, Goossens A (2008) Antibiotic prophylaxis in urologic procedures: a systematic review. Eur Urol 54(6):1270–1286CrossRefPubMed
6.
Dogan HS, Sahin A, Cetinkaya Y, Akdogan B, Ozden E, Kendi S (2002) Antibiotic prophylaxis in percutaneous nephrolithotomy: prospective study in 81 patients. J Endourol Endourol Soc 16(9):649–653CrossRef
7.
Mariappan P, Loong CW (2004) Midstream urine culture and sensitivity test is a poor predictor of infected urine proximal to the obstructing ureteral stone or infected stones: a prospective clinical study. J Urol 171(6 Pt 1):2142–2145CrossRefPubMed
8.
Mariappan P, Smith G, Bariol SV, Moussa SA, Tolley DA (2005) Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol 173(5):1610–1614CrossRefPubMed
9.
Skolarikos A, de la Rosette J (2008) Prevention and treatment of complications following percutaneous nephrolithotomy. Curr Opin Urol 18(2):229–234CrossRefPubMed
10.
Lam HS, Lingeman JE, Barron M, Newman DM, Mosbaugh PG, Steele RE et al (1992) Staghorn calculi: analysis of treatment results between initial percutaneous nephrostolithotomy and extracorporeal shock wave lithotripsy monotherapy with reference to surface area. J Urol 147(5):1219–1225CrossRefPubMed
11.
Meretyk S, Gofrit ON, Gafni O, Pode D, Shapiro A, Verstandig A et al (1997) Complete staghorn calculi: random prospective comparison between extracorporeal shock wave lithotripsy monotherapy and combined with percutaneous nephrostolithotomy. J Urol 157(3):780–786CrossRefPubMed
12.
Duvdevani M, Lorber G, Gofrit ON, Latke A, Katz R, Landau EH et al (2010) Fever after shockwave lithotripsy–risk factors and indications for prophylactic antimicrobial treatment. J Endourol Endourol Soc 24(2):277–281CrossRef
13.
Clayman RV (1999) Incidence of urinary tract infection in patients without bacteriuria undergoing SWL: comparison of stone types. J Urol 161(2):727–728PubMed
14.
Wolf JS Jr, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Schaeffer AJ et al (2008) Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 179(4):1379–1390CrossRefPubMed
15.
Pearle MS, Roehrborn CG (1997) Antimicrobial prophylaxis prior to shock wave lithotripsy in patients with sterile urine before treatment: a meta-analysis and cost-effectiveness analysis. Urology 49(5):679–686CrossRefPubMed
16.
Grabe M BR, Bjerklund Johansen TE, Cai T, Çek M, Köves B, Naber KG, Pickard RS, Tenke P, Wagenlehner F, Wullt B (2015) Guidelines on urological infection. http://​www.​uroweb.​org. Accessed 30 Sept 2016 (cited 2016)
17.
Bierkens AF, Hendrikx AJ, Ezz el Din KE, de la Rosette JJ, Horrevorts A, Doesburg W et al (1997) The value of antibiotic prophylaxis during extracorporeal shock wave lithotripsy in the prevention of urinary tract infections in patients with urine proven sterile prior to treatment. Eur Urol 31(1):30–35PubMed
18.
Deliveliotis C, Giftopoulos A, Koutsokalis G, Raptidis G, Kostakopoulos A (1997) The necessity of prophylactic antibiotics during extracorporeal shock wave lithotripsy. Int Urol Nephrol 29(5):517–521CrossRefPubMed
19.
Lu Y, Tianyong F, Ping H, Liangren L, Haichao Y, Qiang W (2012) Antibiotic prophylaxis for shock wave lithotripsy in patients with sterile urine before treatment may be unnecessary: a systematic review and meta-analysis. J Urol 188(2):441–448CrossRefPubMed
20.
Honey RJ, Ordon M, Ghiculete D, Wiesenthal JD, Kodama R, Pace KT (2013) A prospective study examining the incidence of bacteriuria and urinary tract infection after shock wave lithotripsy with targeted antibiotic prophylaxis. J Urol 189(6):2112–2117CrossRefPubMed
21.
Hsieh CH, Yang SS, Chang SJ (2016) The effectiveness of prophylactic antibiotics with oral levofloxacin against post-shock wave lithotripsy infectious complications: a randomized controlled trial. Surg Infect (Larchmt) 17(3):346–351CrossRef
22.
de la Rosette J, Denstedt J, Geavlete P, Keeley F, Matsuda T, Pearle M et al (2014) The clinical research office of the endourological society ureteroscopy global study: indications, complications, and outcomes in 11,885 patients. J Endourol Endourol Soc 28(2):131–139CrossRef
23.
Berardinelli F, De Francesco P, Marchioni M, Cera N, Proietti S, Hennessey D et al (2016) Infective complications after retrograde intrarenal surgery: a new standardized classification system. Int Urol Nephrol
24.
Martov A, Gravas S, Etemadian M, Unsal A, Barusso G, D’Addessi A et al (2015) Postoperative infection rates in patients with a negative baseline urine culture undergoing ureteroscopic stone removal: a matched case-control analysis on antibiotic prophylaxis from the CROES URS global study. J Endourol Endourol Soc 29(2):171–180CrossRef
25.
Blackmur JP, Maitra NU, Marri RR, Housami F, Malki M, McIlhenny C (2016) Analysis of factors’ association with risk of postoperative urosepsis in patients undergoing ureteroscopy for treatment of stone disease. J Endourol Endourol Soc 30(9):963–969CrossRef
26.
Mitsuzuka K, Nakano O, Takahashi N, Satoh M (2016) Identification of factors associated with postoperative febrile urinary tract infection after ureteroscopy for urinary stones. Urolithiasis 44(3):257–262CrossRefPubMed
27.
Moses RA, Ghali FM, Pais VM Jr, Hyams ES (2016) Unplanned hospital return for infection following ureteroscopy—can we identify modifiable risk factors?. J Urol 195(4P1): 931–936
28.
Sohn DW, Kim SW, Hong CG, Yoon BI, Ha US, Cho YH (2013) Risk factors of infectious complication after ureteroscopic procedures of the upper urinary tract. J Infect Chemother 19(6):1102–1108CrossRefPubMed
29.
Eswara JR, Shariftabrizi A, Sacco D (2013) Positive stone culture is associated with a higher rate of sepsis after endourological procedures. Urolithiasis 41(5):411–414CrossRefPubMed
30.
Knopf HJ, Graff HJ, Schulze H (2003) Perioperative antibiotic prophylaxis in ureteroscopic stone removal. Eur Urol 44(1):115–118CrossRefPubMed
31.
Hsieh CH, Yang SS, Lin CD, Chang SJ (2014) Are prophylactic antibiotics necessary in patients with preoperative sterile urine undergoing ureterorenoscopic lithotripsy? BJU Int 113(2):275–280CrossRefPubMed
32.
Lo CW, Yang SS, Hsieh CH, Chang SJ (2015) Effectiveness of prophylactic antibiotics against post-ureteroscopic lithotripsy infections: systematic review and meta-analysis. Surg Infect (Larchmt) 16(4):415–420CrossRef
33.
Preminger GM, Tiselius HG, Assimos DG, Alken P, Buck C, Gallucci M et al (2007) 2007 guideline for the management of ureteral calculi. J Urol 178(6):2418–2434CrossRefPubMed
34.
Kau E NC, Fuchs G (2010) Complications of ureteroscopic surgery. In: Taneja SS (ed) Complications of urologic surgery: prevention and management, 4th edn. Elsevier, Philadelphia
35.
Johnson DB, Pearle MS (2004) Complications of ureteroscopy. Urol Clin North Am 31(1):157–171CrossRefPubMed
36.
Auge BK, Pietrow PK, Lallas CD, Raj GV, Santa-Cruz RW, Preminger GM (2004) Ureteral access sheath provides protection against elevated renal pressures during routine flexible ureteroscopic stone manipulation. J Endourol Endourol Soc 18(1):33–36CrossRef
37.
Rehman J, Monga M, Landman J, Lee DI, Felfela T, Conradie MC et al (2003) Characterization of intrapelvic pressure during ureteropyeloscopy with ureteral access sheaths. Urology 61(4):713–718CrossRefPubMed
38.
Ramaswamy K, Shah O (2012) Antibiotic prophylaxis after uncomplicated ureteroscopic stone treatment: is there a difference? J Endourol Endourol Soc 26(2):122–125CrossRef
39.
Chew BH, Flannigan R, Kurtz M, Gershman B, Arsovska O, Paterson RF et al (2016) A single dose of intraoperative antibiotics is sufficient to prevent urinary tract infection during ureteroscopy. J Endourol Endourol Soc 30(1):63–68CrossRef
40.
Angus DC, van der Poll T (2013) Severe sepsis and septic shock. N Engl J Med 369(9):840–851CrossRefPubMed
41.
Preminger GM, Assimos DG, Lingeman JE, Nakada SY, Pearle MS, Wolf JS Jr. et al (2005) Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol 173(6):1991–2000CrossRefPubMed
42.
43.
Draga RO, Kok ET, Sorel MR, Bosch RJ, Lock TM (2009) Percutaneous nephrolithotomy: factors associated with fever after the first postoperative day and systemic inflammatory response syndrome. J Endourol Endourol Soc 23(6):921–927CrossRef
44.
Michel MS, Trojan L, Rassweiler JJ (2007) Complications in percutaneous nephrolithotomy. Eur Urol 51(4):899–906 (discussion) CrossRefPubMed
45.
Seitz C, Desai M, Hacker A, Hakenberg OW, Liatsikos E, Nagele U et al (2012) Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy. Eur Urol 61(1):146–158CrossRefPubMed
46.
Mariappan P, Tolley DA (2005) Endoscopic stone surgery: minimizing the risk of post-operative sepsis. Curr Opin Urol 15(2):101–105CrossRefPubMed
47.
Gonen M, Turan H, Ozturk B, Ozkardes H (2008) Factors affecting fever following percutaneous nephrolithotomy: a prospective clinical study. J Endourol Endourol Soc 22(9):2135–2138CrossRef
48.
Gutierrez J, Smith A, Geavlete P, Shah H, Kural AR, de Sio M et al (2013) Urinary tract infections and post-operative fever in percutaneous nephrolithotomy. World J Urol 31(5):1135–1140CrossRefPubMed
49.
Lojanapiwat B, Kitirattrakarn P (2011) Role of preoperative and intraoperative factors in mediating infection complication following percutaneous nephrolithotomy. Urol Int 86(4):448–452CrossRefPubMed
50.
Korets R, Graversen JA, Kates M, Mues AC, Gupta M (2011) Post-percutaneous nephrolithotomy systemic inflammatory response: a prospective analysis of preoperative urine, renal pelvic urine and stone cultures. J Urol 186(5):1899–1903CrossRefPubMed
51.
Fourcade RO (1990) Antibiotic prophylaxis with cefotaxime in endoscopic extraction of upper urinary tract stones: a randomized study. The Cefotaxime Cooperative Group. The Journal of antimicrobial chemotherapy 26(Suppl A): 77–83CrossRef
52.
Charton M, Vallancien G, Veillon B, Brisset JM (1986) Urinary tract infection in percutaneous surgery for renal calculi. J Urol 135(1):15–17CrossRefPubMed
53.
Gravas S, Montanari E, Geavlete P, Onal B, Skolarikos A, Pearle M et al (2012) Postoperative infection rates in low risk patients undergoing percutaneous nephrolithotomy with and without antibiotic prophylaxis: a matched case control study. J Urol 188(3):843–847CrossRefPubMed
54.
Cutajar CL (1992) Norfloxacin prophylaxis for endoscopic urological surgery. Br J Urol 69(4):421–424CrossRefPubMed
55.
Demirtas A, Yildirim YE, Sofikerim M, Kaya EG, Akinsal EC, Tombul ST et al (2012) Comparison of infection and urosepsis rates of ciprofloxacin and ceftriaxone prophylaxis before percutaneous nephrolithotomy: a prospective and randomised study. Sci World J 2012:916381CrossRef
56.
Ingles JA TD (1988) Antibiotic prophylaxis at the time of percutaneous stone surgery. J Endourol Endourol Soc 2(1):59–62CrossRef
57.
Seyrek M, Binbay M, Yuruk E, Akman T, Aslan R, Yazici O et al (2012) Perioperative prophylaxis for percutaneous nephrolithotomy: randomized study concerning the drug and dosage. J Endourol Endourol Soc 26(11):1431–1436CrossRef
58.
Tuzel E, Aktepe OC, Akdogan B (2013) Prospective comparative study of two protocols of antibiotic prophylaxis in percutaneous nephrolithotomy. J Endourol Endourol Soc 27(2):172–176CrossRef
59.
Deshmukh S, Sternberg K, Hernandez N, Eisner BH (2015) Compliance with American urological association guidelines for post-percutaneous nephrolithotomy antibiotics does not appear to increase rates of infection. J Urol 194(4):992–996CrossRefPubMed
60.
Moses R, Agarwal D, Raffin E, Viers B, Sharma V, Krambeck A et al (2016) Post PCNL SIRS is not associated with unplanned readmission. Urology
61.
Bozkurt IH, Aydogdu O, Yonguc T, Koras O, Sen V, Yarimoglu S et al (2015) Predictive value of leukocytosis for infectious complications after percutaneous nephrolithotomy. Urology 86(1):25–29CrossRefPubMed
62.
Patel N, Shi W, Liss M, Raheem O, Wenzler D, Schallhorn C et al (2015) Multidrug resistant bacteriuria before percutaneous nephrolithotomy predicts for postoperative infectious complications. J Endourol Endourol Soc 29(5):531–536CrossRef
63.
Margel D, Ehrlich Y, Brown N, Lask D, Livne PM, Lifshitz DA (2006) Clinical implication of routine stone culture in percutaneous nephrolithotomy—a prospective study. Urology 67(1):26–29CrossRefPubMed
64.
Roushani A, Falahatkar S, Sharifi SH, Mahfoozi L, Saadat SM, Allahkhah A et al (2014) Intra-operative stone culture as an independent predictor of systemic inflammatory response syndrome after percutaneous nephrolithotomy. Urolithiasis 42(5):455–459CrossRefPubMed
65.
Shoshany O, Margel D, Finz C, Ben-Yehuda O, Livne PM, Holand R et al (2015) Percutaneous nephrolithotomy for infection stones: what is the risk for postoperative sepsis? A retrospective cohort study. Urolithiasis 43(3):237–242CrossRefPubMed
66.
Cockerill PA, Rivera ME, Krambeck AE (2014) Analysis of the utility of stone gram stain in urolithiasis treated with percutaneous nephrolithotomy. Urology 83(6):1254–1257CrossRefPubMed
67.
Koras O, Bozkurt IH, Yonguc T, Degirmenci T, Arslan B, Gunlusoy B et al (2015) Risk factors for postoperative infectious complications following percutaneous nephrolithotomy: a prospective clinical study. Urolithiasis 43(1):55–60CrossRefPubMed
68.
Rivera M, Viers B, Cockerill P, Agarwal D, Mehta R, Krambeck A (2016) Pre- and postoperative predictors of infection-related complications in patients undergoing percutaneous nephrolithotomy. J Endourol Endourol Soc 30(9):982–986CrossRef
69.
Mariappan P, Smith G, Moussa SA, Tolley DA (2006) One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. BJU Int 98(5):1075–1079CrossRefPubMed
70.
Bag S, Kumar S, Taneja N, Sharma V, Mandal AK, Singh SK (2011) One week of nitrofurantoin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. Urology 77(1):45–49CrossRefPubMed
71.
Alruwaily AF, Eisner BH, Bierlein MJ, Ghani KR, Wolf JS Jr, Hollenbeck BK et al (2015) Statin use and risk of sepsis after percutaneous nephrolithotomy. J Endourol Endourol Soc 29(10):1126–1130CrossRef
72.
Jou YC, Lu CL, Chen FH, Shen CH, Cheng MC, Lin SH et al (2015) Contributing factors for fever after tubeless percutaneous nephrolithotomy. Urology 85(3):527–530CrossRefPubMed
73.
Wang Y, Jiang F, Wang Y, Hou Y, Zhang H, Chen Q et al (2012) Post-percutaneous nephrolithotomy septic shock and severe hemorrhage: a study of risk factors. Urol Int 88(3):307–310CrossRefPubMed
74.
Matlaga BR SO, Assimos DG (2006) Complications of percutaneous approaches, including incisions. In: Nakada SY, Pearle MS (eds) Advanced endourology the complete clinical guide. Humana Press Inc., Totowa, pp 283–297CrossRef
75.
Aron M, Goel R, Gupta NP, Seth A (2005) Incidental detection of purulent fluid in kidney at percutaneous nephrolithotomy for branched renal calculi. J Endourol Endourol Soc 19(2):136–139CrossRef
76.
Hosseini MM, Basiri A, Moghaddam SM (2007) Percutaneous nephrolithotomy of patients with staghorn stone and incidental purulent fluid suggestive of infection. J Endourol Endourol Soc 21(12):1429–1432CrossRef
77.
Etemadian M, Haghighi R, Madineay A, Tizeno A, Fereshtehnejad SM (2008) Delayed versus same-day percutaneous nephrolithotomy in patients with aspirated cloudy urine. Urol J 5(1):28–33PubMed
Metadaten
Titel
Antibiotic use and the prevention and management of infectious complications in stone disease
verfasst von
Daniel A. Wollin
Adrian D. Joyce
Mantu Gupta
Michael Y. C. Wong
Pilar Laguna
Stavros Gravas
Jorge Gutierrez
Luigi Cormio
Kunjie Wang
Glenn M. Preminger
Publikationsdatum
03.02.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 9/2017
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-017-2005-9

Weitere Artikel der Ausgabe 9/2017

World Journal of Urology 9/2017 Zur Ausgabe

Topic Paper

Treatment selection for urolithiasis: percutaneous nephrolithomy, ureteroscopy, shock wave lithotripsy, and active monitoring

Original Article

Peri-operative allogeneic blood transfusion and outcomes after radical cystectomy: a population-based study

News

SIU Newsletter - September 2017

Topic Paper

Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease

Original Article

Androgen deprivation therapy and the risk of parkinsonism in men with prostate cancer

Letter to the Editor

Reply to: 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. Hamdy et al. NEJM October 2016

Neu im Fachgebiet Urologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Prostatakarzinom: EU initiiert neues Screeningkonzept

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Blasenkarzinom – Biomarker statt Zytologie?
weitere anzeigen

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen